Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo

Published:2019-08-01 Issue:8 Volume:155 Page:929
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Lee Ji Hae¹,Kwon Hyuck Sun¹,Jung Han Mi¹,Lee Hyunyong²,Kim Gyong Moon¹,Yim Hyeon Woo³,Bae Jung Min¹

Affiliation:

1. Department of Dermatology, St Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

2. Clinical Research Coordinating Center, Catholic Medical Center, The Catholic University of Korea, Seoul, Korea

3. Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/article-pdf/155/8/929/17752750/jamadermatology_lee_2019_oi_190023.pdf

Reference77 articles.

1. Vitiligo: a comprehensive overview—part I: introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up.;Alikhan;J Am Acad Dermatol,2011

2. Factors affecting quality of life in patients with vitiligo: a nationwide study.;Bae;Br J Dermatol,2018

3. Guidelines for the management of vitiligo: the European Dermatology Forum consensus.;Taieb;Br J Dermatol,2013

4. Guidelines for the diagnosis and treatment of vitiligo in Japan.;Oiso;J Dermatol,2013

5. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: a systematic review and meta-analysis of randomized controlled trials (RCTs).;Bae;J Am Acad Dermatol,2016

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo;Archives of Dermatological Research;2024-07-18

2. Association of Countries’ Atopic Dermatitis Burden and Sociodemographic Index with Topical Calcineurin Inhibitor Utilization;Dermatitis®;2024-07-03

3. Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo;Archives of Dermatological Research;2024-06-08

4. Implication of colloidal therapeutics in the treatment of vitiligo: Portray of signaling cascade, current drug-targets and preclinical and clinical evidences;Journal of Drug Delivery Science and Technology;2024-06

5. Topical Tacrolimus Ointment Alone versus in Combination with Microneedling for Refractory Stable Vitiligo;Journal of the College of Physicians and Surgeons Pakistan;2024-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3